FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource CodeSystem/FHIR Server from package tw.gov.mohw.nhi.pas#1.0.1 (110 ms)

Package tw.gov.mohw.nhi.pas
Type CodeSystem
Id Id
FHIR Version R4
Source https://twcore.mohw.gov.tw/ig/pas/https://twcore.mohw.gov.tw/ig/pas/1.0.1/CodeSystem-nhi-apply-reason.html
Url https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-apply-reason
Version 1.0.1
Status active
Date 2024-12-06
Name NHIApplyReason
Title NHI-健保事前審查-給付適應症
Experimental False
Realm tw
Authority national
Description 臺灣衛生福利部中央健康保險署「給付適應症」代碼,代碼出版日期:2024-12-06;資料所屬單位:臺灣衛生福利部中央健康保險署。
Content complete

Resources that use this resource

ValueSet
nhi-apply-reason NHI-健保事前審查-給付適應症值集

Resources that this resource uses

No resources found



Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem nhi-apply-reason

This case-sensitive code system https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-apply-reason defines the following codes:

CodeDisplay
C50P1 早期乳癌-未發生腋下淋巴結轉移
C50P2 早期乳癌-具腋下淋巴結轉移
C50R1 轉移性乳癌
C16R1 轉移性胃癌
P001 黑色素瘤
P011 非小細胞肺癌-SQ-2線
P012 非小細胞肺癌-Adeno-3線
P013 非小細胞肺癌-1線
P014 鱗狀非小細胞肺癌第一線用藥(併用化療)
P021 小細胞肺癌(併用化療)
P031 典型何杰金氏淋巴瘤
P041 泌尿道上皮癌-2線
P042 泌尿道上皮癌-1線
P043 局部晚期或轉移性泌尿道上皮癌之維持療法
P052 胃癌-1線(併用化療)
P061 腎細胞癌
P072 晚期肝細胞癌-1線(併用標靶bevacizumab)
P081 頭頸部鱗狀細胞癌第二線用藥
P082 頭頸部鱗狀細胞癌第一線用藥
P091 默克細胞癌
P101 食道鱗狀細胞癌
P111 惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)

Source

{
  "resourceType" : "CodeSystem",
  "id" : "nhi-apply-reason",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem nhi-apply-reason</b></p><a name=\"nhi-apply-reason\"> </a><a name=\"hcnhi-apply-reason\"> </a><a name=\"nhi-apply-reason-en-US\"> </a><p>This case-sensitive code system <code>https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-apply-reason</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">C50P1<a name=\"nhi-apply-reason-C50P1\"> </a></td><td>早期乳癌-未發生腋下淋巴結轉移</td></tr><tr><td style=\"white-space:nowrap\">C50P2<a name=\"nhi-apply-reason-C50P2\"> </a></td><td>早期乳癌-具腋下淋巴結轉移</td></tr><tr><td style=\"white-space:nowrap\">C50R1<a name=\"nhi-apply-reason-C50R1\"> </a></td><td>轉移性乳癌</td></tr><tr><td style=\"white-space:nowrap\">C16R1<a name=\"nhi-apply-reason-C16R1\"> </a></td><td>轉移性胃癌</td></tr><tr><td style=\"white-space:nowrap\">P001<a name=\"nhi-apply-reason-P001\"> </a></td><td>黑色素瘤</td></tr><tr><td style=\"white-space:nowrap\">P011<a name=\"nhi-apply-reason-P011\"> </a></td><td>非小細胞肺癌-SQ-2ç·š</td></tr><tr><td style=\"white-space:nowrap\">P012<a name=\"nhi-apply-reason-P012\"> </a></td><td>非小細胞肺癌-Adeno-3ç·š</td></tr><tr><td style=\"white-space:nowrap\">P013<a name=\"nhi-apply-reason-P013\"> </a></td><td>非小細胞肺癌-1ç·š</td></tr><tr><td style=\"white-space:nowrap\">P014<a name=\"nhi-apply-reason-P014\"> </a></td><td>鱗狀非小細胞肺癌第一線用藥(併用化療)</td></tr><tr><td style=\"white-space:nowrap\">P021<a name=\"nhi-apply-reason-P021\"> </a></td><td>小細胞肺癌(併用化療)</td></tr><tr><td style=\"white-space:nowrap\">P031<a name=\"nhi-apply-reason-P031\"> </a></td><td>典型何杰金氏淋巴瘤</td></tr><tr><td style=\"white-space:nowrap\">P041<a name=\"nhi-apply-reason-P041\"> </a></td><td>泌尿道上皮癌-2ç·š</td></tr><tr><td style=\"white-space:nowrap\">P042<a name=\"nhi-apply-reason-P042\"> </a></td><td>泌尿道上皮癌-1ç·š</td></tr><tr><td style=\"white-space:nowrap\">P043<a name=\"nhi-apply-reason-P043\"> </a></td><td>局部晚期或轉移性泌尿道上皮癌之維持療法</td></tr><tr><td style=\"white-space:nowrap\">P052<a name=\"nhi-apply-reason-P052\"> </a></td><td>胃癌-1ç·š(併用化療)</td></tr><tr><td style=\"white-space:nowrap\">P061<a name=\"nhi-apply-reason-P061\"> </a></td><td>腎細胞癌</td></tr><tr><td style=\"white-space:nowrap\">P072<a name=\"nhi-apply-reason-P072\"> </a></td><td>晚期肝細胞癌-1ç·š(併用標靶bevacizumab)</td></tr><tr><td style=\"white-space:nowrap\">P081<a name=\"nhi-apply-reason-P081\"> </a></td><td>頭頸部鱗狀細胞癌第二線用藥</td></tr><tr><td style=\"white-space:nowrap\">P082<a name=\"nhi-apply-reason-P082\"> </a></td><td>頭頸部鱗狀細胞癌第一線用藥</td></tr><tr><td style=\"white-space:nowrap\">P091<a name=\"nhi-apply-reason-P091\"> </a></td><td>默克細胞癌</td></tr><tr><td style=\"white-space:nowrap\">P101<a name=\"nhi-apply-reason-P101\"> </a></td><td>食道鱗狀細胞癌</td></tr><tr><td style=\"white-space:nowrap\">P111<a name=\"nhi-apply-reason-P111\"> </a></td><td>惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)</td></tr></table></div>"
  },
  "url" : "https://twcore.mohw.gov.tw/ig/pas/CodeSystem/nhi-apply-reason",
  "version" : "1.0.1",
  "name" : "NHIApplyReason",
  "title" : "NHI-健保事前審查-給付適應症",
  "status" : "active",
  "experimental" : false,
  "date" : "2024-12-06",
  "publisher" : "衛生福利部中央健康保險署",
  "contact" : [
    {
      "name" : "衛生福利部中央健康保險署",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.nhi.gov.tw"
        }
      ]
    }
  ],
  "description" : "臺灣衛生福利部中央健康保險署「給付適應症」代碼,代碼出版日期:2024-12-06;資料所屬單位:臺灣衛生福利部中央健康保險署。",
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 22,
  "concept" : [
    {
      "code" : "C50P1",
      "display" : "早期乳癌-未發生腋下淋巴結轉移"
    },
    {
      "code" : "C50P2",
      "display" : "早期乳癌-具腋下淋巴結轉移"
    },
    {
      "code" : "C50R1",
      "display" : "轉移性乳癌"
    },
    {
      "code" : "C16R1",
      "display" : "轉移性胃癌"
    },
    {
      "code" : "P001",
      "display" : "黑色素瘤"
    },
    {
      "code" : "P011",
      "display" : "非小細胞肺癌-SQ-2ç·š"
    },
    {
      "code" : "P012",
      "display" : "非小細胞肺癌-Adeno-3ç·š"
    },
    {
      "code" : "P013",
      "display" : "非小細胞肺癌-1ç·š"
    },
    {
      "code" : "P014",
      "display" : "鱗狀非小細胞肺癌第一線用藥(併用化療)"
    },
    {
      "code" : "P021",
      "display" : "小細胞肺癌(併用化療)"
    },
    {
      "code" : "P031",
      "display" : "典型何杰金氏淋巴瘤"
    },
    {
      "code" : "P041",
      "display" : "泌尿道上皮癌-2ç·š"
    },
    {
      "code" : "P042",
      "display" : "泌尿道上皮癌-1ç·š"
    },
    {
      "code" : "P043",
      "display" : "局部晚期或轉移性泌尿道上皮癌之維持療法"
    },
    {
      "code" : "P052",
      "display" : "胃癌-1ç·š(併用化療)"
    },
    {
      "code" : "P061",
      "display" : "腎細胞癌"
    },
    {
      "code" : "P072",
      "display" : "晚期肝細胞癌-1ç·š(併用標靶bevacizumab)"
    },
    {
      "code" : "P081",
      "display" : "頭頸部鱗狀細胞癌第二線用藥"
    },
    {
      "code" : "P082",
      "display" : "頭頸部鱗狀細胞癌第一線用藥"
    },
    {
      "code" : "P091",
      "display" : "默克細胞癌"
    },
    {
      "code" : "P101",
      "display" : "食道鱗狀細胞癌"
    },
    {
      "code" : "P111",
      "display" : "惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)"
    }
  ]
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.